Page last updated: 2024-10-27

foscarnet and Neoplasms

foscarnet has been researched along with Neoplasms in 5 studies

Foscarnet: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
phosphonoformic acid : Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity.

Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

Research Excerpts

ExcerptRelevanceReference
"Although foscarnet is a promising alternative for the treatment of cytomegalovirus (CMV) infection, its toxicity can be significant in patients with advanced age."7.74Reduced dose of foscarnet as preemptive therapy for cytomegalovirus infection following reduced-intensity cord blood transplantation. ( Hori, A; Kami, M; Kato, D; Kusumi, E; Masuoka, K; Matsumura, T; Miyakoshi, S; Morinaga, S; Murashige, N; Narimatsu, H; Shibata, T; Taniguchi, S; Wake, A; Yuji, K, 2007)
"Although foscarnet is a promising alternative for the treatment of cytomegalovirus (CMV) infection, its toxicity can be significant in patients with advanced age."3.74Reduced dose of foscarnet as preemptive therapy for cytomegalovirus infection following reduced-intensity cord blood transplantation. ( Hori, A; Kami, M; Kato, D; Kusumi, E; Masuoka, K; Matsumura, T; Miyakoshi, S; Morinaga, S; Murashige, N; Narimatsu, H; Shibata, T; Taniguchi, S; Wake, A; Yuji, K, 2007)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Narimatsu, H1
Kami, M1
Kato, D1
Matsumura, T1
Murashige, N1
Kusumi, E1
Yuji, K1
Hori, A1
Shibata, T1
Masuoka, K1
Wake, A1
Miyakoshi, S1
Morinaga, S1
Taniguchi, S1
Lusso, P1
Gallo, RC1
Freifeld, AG1
Ljungman, P1
Baker, R1

Reviews

3 reviews available for foscarnet and Neoplasms

ArticleYear
Human herpesvirus 6.
    Bailliere's clinical haematology, 1995, Volume: 8, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Adult; Animals; Antibodies, Viral; Base Sequence; Child; Child,

1995
Infectious complications in the immunocompromised host. The antimicrobial armamentarium.
    Hematology/oncology clinics of North America, 1993, Volume: 7, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Aminoglycosides; Amphotericin B; Anti-Bacterial Agent

1993
Cytomegalovirus pneumonia: presentation, diagnosis, and treatment.
    Seminars in respiratory infections, 1995, Volume: 10, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus I

1995

Other Studies

2 other studies available for foscarnet and Neoplasms

ArticleYear
Reduced dose of foscarnet as preemptive therapy for cytomegalovirus infection following reduced-intensity cord blood transplantation.
    Transplant infectious disease : an official journal of the Transplantation Society, 2007, Volume: 9, Issue:1

    Topics: Adolescent; Adult; Aged; Antigens, Viral; Antiviral Agents; Cord Blood Stem Cell Transplantation; Cy

2007
Medicare may not reimburse for certain AIDS and cancer drugs.
    BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation, 1995

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; Hu

1995